Polymorphisms in Type 2 Deiodinase Are Not Associated with Well-Being, Neurocognitive Functioning, and Preference for Combined Thyroxine/3,5,3′-Triiodothyronine Therapy
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Some patients on levothyroxine replacement display significant impairment in psychological well-being, compared with sex- and age-matched controls. Levothyroxine-treated patients can be assumed to derive T3 exclusively from deiodination of T4, which, in the central nervous system, is regulated by type II deiodinase (DII). OBJECTIVE: We investigated whether two recently identified polymorphisms in the DII gene (DII-ORFa-Gly3Asp and DII-Thr92Ala) are determinants of well-being and neurocognitive functioning and associated with a preference for replacement with a combination of T3 and T4. METHODS: Genotypes for both polymorphisms were determined in 141 patients with primary autoimmune hypothyroidism, adequately treated with levothyroxine monotherapy and participating in a randomized clinical trial comparing T4 therapy with T4/T3 combination therapy. Questionnaires on well-being and neurocognitive tests were performed at baseline. RESULTS: Allele frequencies in patients with primary hypothyroidism were similar to those of healthy blood bank donors (32.0 vs. 33.9% for DII-ORFa-Gly3Asp and 40.4 vs. 38.8% for DII-Thr92Ala). DII polymorphisms were not associated with measures of well-being, neurocognitive functioning, or preference for combined T4/T3 therapy. CONCLUSION: The DII-ORFa-Gly3Asp and DII-Thr92Ala polymorphisms do not explain differences in well-being, neurocognitive functioning, or appreciation of T4/T3 combination therapy in patients treated for hypothyroidism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two SNPs in DIO2 including Thr92Ala were not associated with well-being, neurocognitive functioning, and preference for combined L-T4 + L-T3 therapy [64] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [64]
In the citing paper
“Actually, the above mentioned studies, which failed to find any difference between the two approaches, could lack the power to underline such changes, since the DIO2 polymorphism is relatively infrequent (71).”
From The diagnosis and management of central hypothyroidism in 2018 (2019) · cites this paper as [71]
In the citing paper
“However, the patient’s status for two DIO2 variants (DIO2-ORFa-Gly3Asp and DIO2-Thr92Ala) was not associated with thyroid hormone levels or the stated preference for combination therapy.”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [96]
Citations
Cites
Cooper, D. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450406 · Cited by 528
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 1×
“study confirmed that patients, even with a normal TSH, display significant impairment in psychological well-being, compared with sex- and age-matched controls (1).”
ResultBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 1×
“In 1999 a clinical trial reported that combined therapy with T4 and T3 resulted in improved mood, well-being, and cognitive functioning, compared with T4 alone, and that the combination was preferred by most patients (2).”
BackgroundPeeters, R. P., van Toor, H., Klootwijk, W., de Rijke, Y. B., Kuiper, G. G. J. M., Uitterlinden, A. G., & Visser, T. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021592 · Cited by 243
Self-citationToft, A. D. (2001) · New England Journal of Medicine · doi:10.1056/nejmcp010145 · Cited by 231
Walsh, J. P., Shiels, L., Lim, E. M., Bhagat, C. I., Ward, L. C., Stuckey, B. G. A., Dhaliwal, S. S., Chew, G. T., Bhagat, M. C., & Cussons, A. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030249 · Cited by 210
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., & Celi, F. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.880 · Cited by 205
Canani, L. H., Capp, C., Dora, J. M., Meyer, E. L. S., Wagner, M. S., Harney, J. W., Larsen, P. R., Gross, J. L., Bianco, A. C., & Maia, A. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1977 · Cited by 204
Clyde, P. W., Harari, A. E., Getka, E. J., & Shakir, K. M. M. (2003) · JAMA · doi:10.1001/jama.290.22.2952 · Cited by 195
Appelhof, B. C., Fliers, E., Wekking, E. M., Schene, A. H., Huyser, J., Tijssen, J. G. P., Endert, E., van Weert, H. C. P. M., & Wiersinga, W. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2111 · Cited by 183
Self-citation
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationGarber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
“Why do some patients prefer combination therapy to Lthyroxine monotherapy (133)? Some insight into the latter question may be gained from a large-scale study of L-thyroxine and L-triiodothyronine combination therapy in which different responses were observed in patients with different genetic subtypes of type 2 deiodi…”
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Deiodinases: implications of the local control of thyroid hormone action
Bianco, A. C., & Kim, B. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29812 · Cited by 845
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Self-citationPanicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Gereben, B., Zeöld, A., Dentice, M., Salvatore, D., & Bianco, A. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7396-0 · Cited by 207
Treatment for primary hypothyroidism: current approaches and future possibilities
Vaidya, B., Chakera, & Pearce (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s12894 · Cited by 199
Nygaard, B., Jensen, E. W., Kvetny, J., Jarløv, A., & Faber, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0542 · Cited by 153
TSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
Thyroid disease and mental disorders: cause and effect or only comorbidity?
Bunevičius, R., & Prange, A. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283387b50 · Cited by 136
Local control of thyroid hormone action: role of type 2 deiodinase
Williams, G. R., & Bassett, J. H. D. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0448 · Cited by 134
Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Neuropsychiatric Manifestations of Thyroid Disease
Feldman, A. Z., Shrestha, R. T., & Hennessey, J. V. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.005 · Cited by 122
Thyroid hormone therapy for hypothyroidism
Biondi, B., & Cooper, D. S. (2019) · Endocrine · doi:10.1007/s12020-019-02023-7 · Cited by 119
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
Self-citationPhysiological role and regulation of iodothyronine deiodinases: A 2011 update
Marsili, A., Zavacki, A. M., Harney, J. W., & Larsen, P. R. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347465 · Cited by 114
Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report
Centanni, M., Benvenga, S., & Sachmechi, I. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0706-y · Cited by 113
“However, the benefits of that treatment remain controversial [77, 78].”
BackgroundNovel insights into thyroid hormones from the study of common genetic variation
Dayan, C. M., & Panicker, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.19 · Cited by 110
“In a small study that included 141 patients on T 4 replacement, Appelhof et al”
BackgroundGenetics of thyroid function and disease.
Panicker, V. (2011) · Europe PMC (PubMed Central) · Cited by 105
Van Der Deure, W. M., Appelhof, B. C., Peeters, R. P., Wiersinga, W. M., Wekking, E. M., Huyser, J., Schene, A. H., Tijssen, J. G. P., Hoogendijk, W. J. G., Visser, T. J., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03267.x · Cited by 97
Self-citationWouters, H. J. C. M., van Loon, H. C. M., van der Klauw, M. M., Elderson, M. F., Slagter, S. N., Kobold, A. M., Kema, I. P., Links, T. P., van Vliet-Ostaptchouk, J. V., & Wolffenbuttel, B. H. R. (2017) · Thyroid® · doi:10.1089/thy.2016.0199 · Cited by 97
Carlé, A., Faber, J., Steffensen, R., Laurberg, P., & Nygaard, B. (2017) · European Thyroid Journal · doi:10.1159/000469709 · Cited by 93
Genetic determination of the hypothalamic–pituitary–thyroid axis: where do we stand?
Medici, M., Visser, W. E., Visser, T. J., & Peeters, R. P. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1081 · Cited by 92
Self-citationTorlontano, M., Durante, C., Torrente, I., Crocetti, U., Augello, G., Ronga, G., Montesano, T., Travascio, L., Verrienti, A., Bruno, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1067 · Cited by 92
To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?
Calissendorff, J., & Falhammar, H. (2020) · Medicina · doi:10.3390/medicina56010040 · Cited by 90
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination
Köhrle, J. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.04.001 · Cited by 83
Liothyronine use in a 17 year observational population‐based study ‐ the tears study
Leese, G. P., Soto‐Pedre, E., & Donnelly, L. A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13052 · Cited by 75
Hyperthyroidism and clinical depression: a systematic review and meta-analysis
Bode, H., Ivens, B., Bschor, T., Schwarzer, G., Henssler, J. F., & Baethge, C. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02121-7 · Cited by 74
Thyroxine replacement: a clinical endocrinologist’s viewpoint
Eligar, V, Taylor, P., Okosieme, O., Leese, G., & Dayan, C. (2016) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216642255 · Cited by 72
The diagnosis and management of central hypothyroidism in 2018
Persani, L., Cangiano, B., & Bonomi, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0515 · Cited by 64
Dayan, C., & Panicker, V. (2018) · Thyroid Research · doi:10.1186/s13044-018-0045-x · Cited by 62
Butler, P. W., Smith, S. M., Linderman, J. D., Brychta, R. J., Alberobello, A. T., Dubaz, O. M., Luzon, J. A., Skarulis, M. C., Cochran, C. S., Wesley, R. A., et al. (2010) · Thyroid · doi:10.1089/thy.2010.0244 · Cited by 60
Joffe, R. T., Brimacombe, M., Levitt, A. J., & Stagnaro-Green, A. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.5.379 · Cited by 57
Verloop, H., Dekkers, O. M., Peeters, R. P., Schoones, J. W., & Smit, J. W. A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0302 · Cited by 56
Self-citationCaron, P., Grunenwald, S., Persani, L., Borson-Chazot, F., Leroy, R., & Duntas, L. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09691-9 · Cited by 53
“L-tri-iodothyronine (LT3) + LT4 combination therapy [96].”
THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
Wiersinga, W. M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0645 · Cited by 52
Self-citationHeemstra, K. A., Hoftijzer, H. C., Van Der Deure, W. M., Peeters, R. P., Fliers, E., Appelhof, B. C., Wiersinga, W. M., Corssmit, E. P. M., Visser, T. J., & Smit, J. W. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03474.x · Cited by 51
Self-citationFatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism
Louwerens, M., Appelhof, B. C., Verloop, H., Medici, M., Peeters, R. P., Visser, T. J., Boelen, A., Fliers, E., Smit, J. W. A., & Dekkers, O. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0501 · Cited by 50
Self-citationHennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?
Wiersinga, W. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0879 · Cited by 45
Self-citationThe Genetic Basis of Thyroid Function: Novel Findings and New Approaches
Kuś, A., Chaker, L., Teumer, A., Peeters, R. P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz225 · Cited by 44
“The first study was performed by Appelhof et al (71) in 2005, who did not find effects of the DIO2-rs225014 genotype on baseline well-being or appreciation of LT4/LT3 combination therapy in 141 hypothyroid patients (P > 0.”
BackgroundSelf-citationCombination L-T3 and L-T4 therapy for hypothyroidism
Wartofsky, L. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000432611.03732.49 · Cited by 42
Kaminski, J., Miasaki, F. Y., Paz-Filho, G., Graf, H., & Carvalho, G. A. D. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000192 · Cited by 42
“To date, it is still unclear whether polymorphisms play a role in response to therapy in patients with hypothyroidism (45-47).”
BackgroundPhysician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2018) · Thyroid · doi:10.1089/thy.2018.0325 · Cited by 41
Guglielmi, R., Frasoldati, A., Zini, M., Grimaldi, F., Gharib, H., Garber, J. R., & Papini, E. (2016) · Endocrine Practice · doi:10.4158/ep161308.or · Cited by 39
Akirov, A., Fazelzad, R., Ezzat, S., Thabane, L., & Sawka, A. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00477 · Cited by 37
Thyroid hormone replacement: current status and challenges
Okosieme, O. E. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600307 · Cited by 35
Thyroid Hormone Replacement Therapy: Three Simple Questions, Complex Answers
Bianco, A. C., & Casula, S. (2012) · European Thyroid Journal · doi:10.1159/000339447 · Cited by 32
Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2019) · Thyroid · doi:10.1089/thy.2018.0369 · Cited by 31
Escobar-Morreale, H. F., Botella-Carretero, J. I., & Morreale de Escobar, G. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.10.004 · Cited by 30
Kraut, E., & Farahani, P. (2015) · Clinical and Investigative Medicine · doi:10.25011/cim.v38i6.26194 · Cited by 30
Thyroid–Brain Interactions in Neuropsychiatric Disorders
Bunevičius, R., & Prange, A. J. (2010) · Springer eBooks · doi:10.1007/978-4-431-53871-4_2 · Cited by 28
Jonklaas, J., Tefera, E., & Shara, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00031 · Cited by 23
Duntas, L. H. (2017) · Clinical and experimental thyroidology · doi:10.14341/ket2017314-19 · Cited by 23
Does Combination T4 And T3 Therapy Make Sense?
McDermott, M. T. (2012) · Endocrine Practice · doi:10.4158/ep12076.ra · Cited by 18
Cho, Y. Y., Kim, H. J., Jang, H. W., Kim, T. H., Ki, C., Kim, S. W., & Chung, J. H. (2017) · Endocrine · doi:10.1007/s12020-017-1307-4 · Cited by 17
Clinical significance of type 2 iodothyronine deiodinase polymorphism
Maino, F., Cantara, S., Forleo, R., Pilli, T., & Castagna, M. G. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1523714 · Cited by 17
Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
Razvi, S., Mrabeti, S., & Luster, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0205 · Cited by 15
Genetics and phenomics of selenoenzymes—How to identify an impaired biosynthesis?
Schomburg, L. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.011 · Cited by 14
Functional Analysis of Novel Genetic Variation in the Thyroid Hormone Activating Type 2 Deiodinase
Zevenbergen, C., Klootwijk, W., Peeters, R. P., Medici, M., de Rijke, Y. B., Huisman, S. A., Goeman, H. J. M., Boot, E., de Kuijper, G. M., de Waal, K. H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2281 · Cited by 11
Self-citationA Step Forward in Understanding the Relevance of Genetic Variation in Type 2 Deiodinase
Medici, M., Chaker, L., & Peeters, R. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00585 · Cited by 11
Self-citationUse and misuse of thyroid hormone
Topliss, D. J., & Soh, S.-B. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013143 · Cited by 11
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism
Jonklaas, J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.003 · Cited by 10
Jensen, C. Z., Isaksen, J. L., Ahlberg, G., OLESEN, M. S., Nygaard, B., Ellervik, C., & Kanters, J. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad556 · Cited by 8
Schwengber, W. K., Silveira, V. B., Hetzel, G. M., Robaina, A., Ceolin, L., Camelier, M. T. V., Goemann, I. M., Corte, R. R. D., Scheffel, R. S., de Mello, R. G. B., et al. (2022) · Metabolites · doi:10.3390/metabo12050375 · Cited by 7
Uncertainties in endocrine substitution therapy for central endocrine insufficiencies
Persani, L., & Bonomi, M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00027-7 · Cited by 6
Fussey, J. M., Khan, H., Ahsan, S. F., Prashant, R., & Pettit, L. (2017) · Head & Neck · doi:10.1002/hed.24926 · Cited by 5
Steiblienė, V., Bunevičius, A., Savickas, A., Prange, A. J., Nemeroff, C. B., & Bunevičius, R. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.11.007 · Cited by 5
Diagnosis and Treatment of Hypothyroidism
Ashraff, S., & Razvi, S. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_14 · Cited by 4
Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
Hennessey, J. V. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2022.12.013 · Cited by 4
Duntas, L. H., & Wartofsky, L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.11.005 · Cited by 4
Liothyronine use in primary hypothyroidism — current concepts
Concepción‐Zavaleta, M. J., Ildefonso-Najarro, S. P., Paz‐Ibarra, J., Fernández-Dávila, F. V., Condori, D. C. D.-G., Rivera-Fabián, K., Herrera-Cabezas, R. G., & Urteaga, L. A. C. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0093 · Cited by 4
Sakr, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-48775-1_10 · Cited by 4
Zevenbergen, C., Groeneweg, S., Swagemakers, S. M. A., de Jong, A., den Herik, E. M.-V., Rispens, M., Klootwijk, W., Medici, M., de Rijke, Y. B., Meima, M. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01605 · Cited by 4
Self-citationЛечение первичного гипотиреоза: нерешенные вопросы
Моргунова, Т. Б., Madiyarova, M. S., & Fadeyev, V. V. (2015) · Clinical and experimental thyroidology · doi:10.14341/ket2015122-34 · Cited by 4
Eligar, V. S., Taylor, P. N., Okosieme, O. E., & Dayan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00077-8 · Cited by 3
Genetics of Thyroid Function: Relevance for Biology and Disease Management
Sterenborg, R. B. T. M., Peeters, R. P., Visser, W. E., Kuś, A., Smit, J. W. A., Teumer, A., & Medici, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf491 · Cited by 3
Self-citationPersistent Hypothyroid Symptoms Despite Adequate Thyroid Hormone Replacement
McDermott, M. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_23 · Cited by 2
L-T4 and L-T3 combined treatment vs L-T4 alone
Wiersinga, W. M. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.008 · Cited by 2
Self-citationThe thyroid axis function in acute psychotic episode
Steiblienė, V. (2012) · Lithuanian University of Health Sciences · Cited by 2
Regulation of Thyroid Hormone Bioactivity in Health and Disease
Peeters, R. P. (2005) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 2
Self-citationNewman, S. K., & Davies, T. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00120-1 · Cited by 1
Diagnosis and Treatment of Hypothyroidism
Ashraff, S., & Razvi, S. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_14-1 · Cited by 1
Tsanava, I. A., Bulgakova, S. V., & Melikova, A. V. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-5-261-265 · Cited by 1
Heemstra, K. A. (2009) · Leiden Repository (Leiden University) · Cited by 1
Thyroid Genetics and the Cardiovascular System
Kuś, A., Teumer, A., Chaker, L., & Medici, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_15
Optimal Management of Hypothyroidism: Incremental Improvements for use in 2016 and Beyond
Hennessey, J. V. (2016) · Endocrine Practice · doi:10.4158/ep161586.co
Mang, N., Tămaş, L., Mărginean, O., Marian, C., Ursoniu, S., & Anghel, A. (2019) · Revista română de medicină de laborator · doi:10.2478/rrlm-2019-0012
Thyroid and Parathyroid Transplantation
Sakr, M. F. (2024) · Springer eBooks · doi:10.1007/978-3-031-64102-2_18
Thyroid Hormone Therapy and Thyrotropin Suppression
Wartofsky, L. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3314-3_36
Differentiated thyroid carcinoma : treatment and clinical consequences of therapy
Hoftijzer, H. C. (2011) · Leiden Repository (Leiden University)
Sundman, E. (2020) · Helda - University of Helsinki Institutional Repository
(n.d.) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Bosch-García, D. (2012) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Verloop, H. (2017) · Leiden Repository (Leiden University)
Metadata
- Authors
- Appelhof, B. C., Peeters, R. P., Wiersinga, W. M., Visser, T. J., Wekking, E. M., Huyser, J., Schene, A. H., Tijssen, J. G. P., Hoogendijk, W. J. G., & Fliers, E.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Erasmus MC (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-11
- Volume
- 90
- Issue
- 11
- Pages
- 6296-6299
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2097398707
- Cited by
- 91
- References
- 14
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 8 · 2015: 4 · 2014: 7 · 2013: 3 · 2012: 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- type 2 deiodinase, levothyroxine monotherapy, psychological well-being, neurocognitive function, thyroid hormone deiodination, genotype-phenotype correlation
- MeSH terms
- Iodothyronine Deiodinase Type II, Adult, Female, Genotype, Humans, Hypothyroidism, Iodide Peroxidase, Male, Middle Aged, Polymorphism, Genetic, Thyroxine, Triiodothyronine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.